ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,353Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 2456

$565K Total Retail Price of All Prescriptions

Rank: 181 out of 2456

651 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 651 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 651 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 9,547 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 726 590 1 2
LISINOPRIL 629 527 2 1
HYDROCODONE-ACETAMINOPHEN 456 148 S3 3 20
LEVOTHYROXINE SODIUM 438 354 4 4
HYDROCHLOROTHIAZIDE 397 352 5 7
AMLODIPINE BESYLATE 356 312 6 5
CITALOPRAM HBR 316 267 7 14
OMEPRAZOLE 309 235 8 3
FUROSEMIDE 285 268 9 8
ATENOLOL 277 215 10 6
WARFARIN SODIUM 271 236 11 9
TRAZODONE HCL 263 219 12 17
FLUOXETINE HCL 258 201 13 45
DONEPEZIL HCL 209 209 14 23
METOPROLOL SUCCINATE 207 173 15 13
METOPROLOL TARTRATE 200 189 16 10
MIRTAZAPINE 185 175 17 29
METFORMIN HCL 160 110 18 11
PRAVASTATIN SODIUM 134 115 19 15
ATORVASTATIN CALCIUM 133 99 20 12
LOSARTAN POTASSIUM 128 114 21 18
NAMENDA 123 123 22 42
GABAPENTIN 122 111 23 16
PROAIR HFA 122 57 23 22
OXYCODONE HCL 115 45 S2 25 38
ADVAIR DISKUS 115 96 25 36
TRIAMTERENE-HCTZ 113 99 27 53
FLUTICASONE PROPIONATE 110 80 28 30
TRAMADOL HCL 109 68 29 24
ALENDRONATE SODIUM 108 95 30 19
OXYCODONE-ACETAMINOPHEN 108 58 S2 30 35
GLYBURIDE 106 77 R 32 40
POTASSIUM CHLORIDE 103 92 33 33
PREDNISONE 100 82 34 39
DIGOXIN 98 98 35 49
ALLOPURINOL 89 72 36 27
SERTRALINE HCL 83 53 37 21
OXYBUTYNIN CHLORIDE ER 79 38 38 94
CYMBALTA 77 69 39 65
NYSTATIN 75 72 40 99
CYCLOBENZAPRINE HCL 74 0 R 41 77
SPIRIVA 71 23 42 43
QUETIAPINE FUMARATE 71 54 42 47
SPIRONOLACTONE 65 48 44 73
IBUPROFEN 64 23 45 52
AMITRIPTYLINE HCL 59 48 R 46 83
VERAPAMIL ER 57 56 47 91
AZITHROMYCIN 54 34 48 60
ZOSTAVAX 51 46 49 122
RANITIDINE HCL 51 41 49 31
PAROXETINE HCL 50 12 51 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.